110 related articles for article (PubMed ID: 32039744)
1. Gene expression in peripheral blood in treatment-free major depression.
Cuellar-Barboza AB; Sánchez-Ruiz JA; Rodriguez-Sanchez IP; González S; Calvo G; Lugo J; Costilla-Esquivel A; Martínez LE; Ibarra-Ramirez M
Acta Neuropsychiatr; 2020 Feb; ():1-10. PubMed ID: 32039744
[TBL] [Abstract][Full Text] [Related]
2. Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population.
Zhang K; Yang C; Xu Y; Sun N; Yang H; Liu J; Xu Q; Shen Y
J Neural Transm (Vienna); 2010 Mar; 117(3):393-401. PubMed ID: 20033742
[TBL] [Abstract][Full Text] [Related]
3. The combined effects of the BDNF and GSK3B genes modulate the relationship between negative life events and major depressive disorder.
Yang C; Xu Y; Sun N; Ren Y; Liu Z; Cao X; Zhang K
Brain Res; 2010 Oct; 1355():1-6. PubMed ID: 20682308
[TBL] [Abstract][Full Text] [Related]
4. An altered peripheral IL6 response in major depressive disorder.
Money KM; Olah Z; Korade Z; Garbett KA; Shelton RC; Mirnics K
Neurobiol Dis; 2016 May; 89():46-54. PubMed ID: 26804030
[TBL] [Abstract][Full Text] [Related]
5. Identification of key genes and crucial pathways for major depressive disorder using peripheral blood samples and chronic unpredictable mild stress rat models.
He J; Ren Z; Xia W; Zhou C; Bi B; Yu W; Zuo L
PeerJ; 2021; 9():e11694. PubMed ID: 34414022
[TBL] [Abstract][Full Text] [Related]
6. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression.
Joaquim HP; Talib LL; Forlenza OV; Diniz BS; Gattaz WF
J Psychiatr Res; 2012 Aug; 46(8):1053-8. PubMed ID: 22622071
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression.
Ronai Z; Kovacs-Nagy R; Szantai E; Elek Z; Sasvari-Szekely M; Faludi G; Benkovits J; Rethelyi JM; Szekely A
Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):217-22. PubMed ID: 24677591
[TBL] [Abstract][Full Text] [Related]
8. Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression.
Inkster B; Nichols TE; Saemann PG; Auer DP; Holsboer F; Muglia P; Matthews PM
Neuroimage; 2010 Nov; 53(3):908-17. PubMed ID: 20219685
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder.
Tsai SJ; Liou YJ; Hong CJ; Yu YW; Chen TJ
Pharmacogenomics J; 2008 Dec; 8(6):384-90. PubMed ID: 18195729
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide profiling of DNA methylome and transcriptome in peripheral blood monocytes for major depression: A Monozygotic Discordant Twin Study.
Zhu Y; Strachan E; Fowler E; Bacus T; Roy-Byrne P; Zhao J
Transl Psychiatry; 2019 Sep; 9(1):215. PubMed ID: 31477685
[TBL] [Abstract][Full Text] [Related]
11. An association study of clock genes with major depressive disorder.
Li Y; Miao P; Li F; Huang J; Fan L; Chen Q; Zhang Y; Yan F; Gao Y
J Affect Disord; 2023 Nov; 341():147-153. PubMed ID: 37633529
[TBL] [Abstract][Full Text] [Related]
12. Gene Expression Analysis in Three Posttraumatic Stress Disorder Cohorts Implicates Inflammation and Innate Immunity Pathways and Uncovers Shared Genetic Risk With Major Depressive Disorder.
Garrett ME; Qin XJ; Mehta D; Dennis MF; Marx CE; Grant GA; ; ; ; ; Stein MB; Kimbrel NA; Beckham JC; Hauser MA; Ashley-Koch AE
Front Neurosci; 2021; 15():678548. PubMed ID: 34393704
[TBL] [Abstract][Full Text] [Related]
13. Yoga- and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: A randomized controlled trial.
Tolahunase MR; Sagar R; Faiq M; Dada R
Restor Neurol Neurosci; 2018; 36(3):423-442. PubMed ID: 29614706
[TBL] [Abstract][Full Text] [Related]
14. The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population.
Chen J; Wang M; Waheed Khan RA; He K; Wang Q; Li Z; Shen J; Song Z; Li W; Wen Z; Jiang Y; Xu Y; Shi Y; Ji W
J Affect Disord; 2015 Oct; 185():149-55. PubMed ID: 26186530
[TBL] [Abstract][Full Text] [Related]
15. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
[TBL] [Abstract][Full Text] [Related]
16. The Impact of
Santos M; Lima L; Carvalho S; Mota-Pereira J; Pimentel P; Maia D; Correia D; Barroso MF; Gomes S; Cruz A; Medeiros R
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047730
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Biomarker Hsa_circ_0126218 and Functioning Prediction in Peripheral Blood Monocular Cells of Female Patients With Major Depressive Disorder.
Bu T; Qiao Z; Wang W; Yang X; Zhou J; Chen L; Yang J; Xu J; Ji Y; Wang Y; Zhang W; Yang Y; Qiu X; Yu Y
Front Cell Dev Biol; 2021; 9():651803. PubMed ID: 34095115
[TBL] [Abstract][Full Text] [Related]
18. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
Hung YY; Lin CC; Kang HY; Huang TL
Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
[TBL] [Abstract][Full Text] [Related]
19. Blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder.
Yi Z; Li Z; Yu S; Yuan C; Hong W; Wang Z; Cui J; Shi T; Fang Y
PLoS One; 2012; 7(2):e31283. PubMed ID: 22348066
[TBL] [Abstract][Full Text] [Related]
20. Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder.
Mahajan GJ; Vallender EJ; Garrett MR; Challagundla L; Overholser JC; Jurjus G; Dieter L; Syed M; Romero DG; Benghuzzi H; Stockmeier CA
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():177-186. PubMed ID: 29175309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
